A counteracting agent may be the stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, MW 1419, an anti-ulcer peptide per-orally active (12-15) that may also affect many central disturbances (16-23), efficient in inflammatory bowel disease trials (PL 14736) (24, 25) and various wound treatment (26-28), no toxicity reported (12, 13, 24, 25)) which showed various hepatoprotective effects (29-31)
Read safety information Supporting research A selection of peer-reviewed work on AOD 9604/MOTS-C
*B12 10000 is ideal for those seeking to maximize physical performance and increase endurance capacity in their training or development stage
References Kohsaka, A
The cationic amino acid transporter 2 is induced in inflammatory lung models and regulates lung fibrosis
AMERICA Scientist show that VIP peptide not only reduces inflammation but also regulates immune responses and offers neuroprotective benefits, which KPV lacks